Gen. Naravane and Foreign Secretary Shringla are on a two-day visit to Myanmar with an aim to further expand ties in a range of areas including connectivity, defence and security.
In its proposal to govt, Jubilant Life Sciences has said it plans to launch remdesivir as sublingual tablets, which are consumed by placing them under the tongue.
Dept of Pharmaceuticals secretary has asked pharma companies to review implementation of marketing ethics to ensure hoarding & leakages in drug distribution are stopped.
The committee’s decision followed detailed deliberations at a meeting on 13 August. The DCGI will now take a final call on the proposals submitted by the three companies.
Doctors treating Covid-19 patients say their experience of the disease over the past six months has made them more confident in their approach towards it. Here’s how.
Researchers affiliated with a US hospital and a Telangana firm say there might be something fishy about risks associated with remdesivir ‘getting played down’.
The ministry wrote to DCGI, asking it to ascertain how many states, UTs have been covered and which of them are left, as far as the availability and distribution is concerned.
While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS